Aran Research and Development 1982 Ltd (ARAN) - Net Assets

Latest as of June 2025: ILA106.83 Million ILA ≈ $286.42K USD

Based on the latest financial reports, Aran Research and Development 1982 Ltd (ARAN) has net assets worth ILA106.83 Million ILA (≈ $286.42K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA193.01 Million ≈ $517.46K USD) and total liabilities (ILA86.18 Million ≈ $231.04K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Aran Research and Development 1982 Ltd (ARAN) liquid assets ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets ILA106.83 Million
% of Total Assets 55.35%
Annual Growth Rate 8.57%
5-Year Change 80.1%
10-Year Change 98.35%
Growth Volatility 16.91

Aran Research and Development 1982 Ltd - Net Assets Trend (2009–2024)

This chart illustrates how Aran Research and Development 1982 Ltd's net assets have evolved over time, based on quarterly financial data. Also explore ARAN total assets for the complete picture of this company's asset base.

Annual Net Assets for Aran Research and Development 1982 Ltd (2009–2024)

The table below shows the annual net assets of Aran Research and Development 1982 Ltd from 2009 to 2024. For live valuation and market cap data, see Aran Research and Development 1982 Ltd market cap and net worth.

Year Net Assets Change
2024-12-31 ILA108.64 Million
≈ $291.27K
+6.61%
2023-12-31 ILA101.91 Million
≈ $273.21K
+14.65%
2022-12-31 ILA88.89 Million
≈ $238.30K
+31.22%
2021-12-31 ILA67.74 Million
≈ $181.60K
+12.29%
2020-12-31 ILA60.32 Million
≈ $161.73K
+4.80%
2019-12-31 ILA57.56 Million
≈ $154.32K
-4.14%
2018-12-31 ILA60.05 Million
≈ $160.99K
+12.67%
2017-12-31 ILA53.30 Million
≈ $142.88K
-3.63%
2016-12-31 ILA55.30 Million
≈ $148.26K
+0.96%
2015-12-31 ILA54.77 Million
≈ $146.85K
+1.09%
2014-12-31 ILA54.18 Million
≈ $145.26K
+0.47%
2013-12-31 ILA53.93 Million
≈ $144.58K
+53.70%
2012-12-31 ILA35.09 Million
≈ $94.06K
-3.39%
2011-12-31 ILA36.32 Million
≈ $97.36K
-13.27%
2010-12-31 ILA41.88 Million
≈ $112.27K
+32.38%
2009-12-31 ILA31.63 Million
≈ $84.81K
--

Equity Component Analysis

This analysis shows how different components contribute to Aran Research and Development 1982 Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 473.6% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings ILA81.48 Million 78.27%
Common Stock ILA22.62 Million 21.73%
Other Comprehensive Income ILA-4.44 Million -4.27%
Other Components ILA4.44 Million 4.27%
Total Equity ILA104.10 Million 100.00%

Aran Research and Development 1982 Ltd Competitors by Market Cap

The table below lists competitors of Aran Research and Development 1982 Ltd ranked by their market capitalization.

Company Market Cap
Ultimovacs ASA
OL:ULTI
$52.14 Million
Leader Electronics Inc
TW:3058
$52.14 Million
Decibel Cannabis Company Inc
V:DB
$52.16 Million
Matsa Resources Ltd
AU:MAT
$52.17 Million
Davolink Inc.
KQ:340360
$52.13 Million
Grove Collaborative Holdings, Inc.
NYSE:GROV
$52.11 Million
Silvano Fashion Group AS
WAR:SFG
$52.11 Million
Societe de Tayninh SA
PA:TAYN
$52.09 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Aran Research and Development 1982 Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 96,963,000 to 104,096,000, a change of 7,133,000 (7.4%).
  • Net income of 6,816,000 contributed positively to equity growth.
  • Other comprehensive income decreased equity by 34,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income ILA6.82 Million +6.55%
Other Comprehensive Income ILA-34.00K -0.03%
Other Changes ILA351.00K +0.34%
Total Change ILA- 7.36%

Book Value vs Market Value Analysis

This analysis compares Aran Research and Development 1982 Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 201.83x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 567.16x to 201.83x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2012-12-31 ILA7.58 ILA4300.00 x
2013-12-31 ILA10.01 ILA4300.00 x
2014-12-31 ILA11.10 ILA4300.00 x
2015-12-31 ILA10.76 ILA4300.00 x
2016-12-31 ILA11.13 ILA4300.00 x
2017-12-31 ILA10.34 ILA4300.00 x
2018-12-31 ILA11.83 ILA4300.00 x
2019-12-31 ILA11.45 ILA4300.00 x
2020-12-31 ILA12.02 ILA4300.00 x
2021-12-31 ILA13.65 ILA4300.00 x
2022-12-31 ILA17.76 ILA4300.00 x
2023-12-31 ILA19.85 ILA4300.00 x
2024-12-31 ILA21.30 ILA4300.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Aran Research and Development 1982 Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 6.55%
  • The company has moderate efficiency in generating returns from equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 3.13%
  • • Asset Turnover: 1.13x
  • • Equity Multiplier: 1.85x
  • Recent ROE (6.55%) is below the historical average (11.61%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2009 6.25% 3.52% 1.09x 1.64x ILA-1.19 Million
2010 16.54% 9.30% 1.03x 1.73x ILA2.51 Million
2011 8.03% 3.10% 1.43x 1.81x ILA-711.50K
2012 -0.46% -0.18% 1.06x 2.38x ILA-3.54 Million
2013 35.02% 16.77% 1.00x 2.08x ILA11.41 Million
2014 1.97% 1.21% 0.90x 1.81x ILA-4.13 Million
2015 7.24% 3.32% 1.05x 2.08x ILA-1.45 Million
2016 7.78% 4.43% 0.99x 1.78x ILA-1.21 Million
2017 12.81% 4.55% 1.14x 2.47x ILA1.42 Million
2018 15.68% 6.58% 1.23x 1.94x ILA3.28 Million
2019 3.12% 1.53% 1.06x 1.93x ILA-3.85 Million
2020 5.13% 3.14% 0.63x 2.61x ILA-2.86 Million
2021 16.40% 5.32% 0.91x 3.38x ILA4.27 Million
2022 27.08% 13.60% 0.76x 2.64x ILA14.82 Million
2023 16.59% 9.36% 0.76x 2.34x ILA6.39 Million
2024 6.55% 3.13% 1.13x 1.85x ILA-3.59 Million

Industry Comparison

This section compares Aran Research and Development 1982 Ltd's net assets metrics with peer companies in the Conglomerates industry.

Industry Context

  • Industry: Conglomerates
  • Average net assets among peers: $553,074,667
  • Average return on equity (ROE) among peers: 19.24%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Aran Research and Development 1982 Ltd (ARAN) ILA106.83 Million 6.25% 0.81x $52.13 Million
Amanet Management & Systems Ltd (AMAN) $101.37 Million -7.03% 0.75x $29.39 Million
Cohen Dev (CDEV) $23.75 Million 79.58% 0.12x $368.01 Million
Elco Ltd (ELCO) $2.49 Billion 10.39% 3.75x $1.02 Billion
B. Gaon Holdings Ltd (GAON) $391.64 Million 0.19% 1.19x $34.38 Million
Intergama (INTR) $238.99 Million 32.35% 4.37x $37.13 Million
Vision Sigma (VISN) $69.00 Million 0.00% 0.62x $14.65 Million

About Aran Research and Development 1982 Ltd

TA:ARAN Israel Conglomerates
Market Cap
$52.13 Million
ILA19.45 Billion ILA
Market Cap Rank
#21859 Global
#299 in Israel
Share Price
ILA4300.00
Change (1 day)
-2.25%
52-Week Range
ILA2435.00 - ILA4540.00
All Time High
ILA4540.00
About

Aran Research & Development (1982) Ltd. engages in the product design and development, and equipment manufacturing businesses for plastics industry in Israel. It operates through Investments in Ventures and Start-Up Companies; Sale of Equipment and Raw Materials; and Product Development, Design and Manufacture Services segments. The company develops various medical devices, such as cardiovascular… Read more